UB‑UZ Research Partnership

HIV Clinical Pharmacology
& Therapeutics Training

Empowering the next generation of researchers through mentored postgraduate initiatives to advance clinical and translational pharmacology in Zimbabwe and Southern Africa.

The Initiative

Building Research Capacity

The UB‑UZ HIV‑RT established a postgraduate fellowship training initiative to conduct clinical and translational pharmacology research in Zimbabwe. The University at Buffalo (UB) and University of Zimbabwe (UZ) faculty provide mentored training with a focus on current and investigational drug treatment and the clinical pharmacology expertise to integrate with multidisciplinary teams.

Strong institutional support is evident through the participation of administrative leaders at UZ, recognizing the urgent need to support future researchers to address the HIV/AIDS epidemic.

Research Scholars

Research Training

The HIV RT program trains pre‑ and post‑doctoral researchers in HIV clinical pharmacology to advance prevention and treatment strategies. It builds on integrating mentorship, community engagement, and partnerships to address emerging therapies and public health priorities.

Academic Synergy

The program focuses on a group of highly trained individuals who will pursue research programs within the multidisciplinary environment at UZ, with continued mentoring and career development after the training period ends.

Research Scholars
Research Scholars

Advancing the frontier of clinical pharmacology through dedicated female researchers.

Laboratory
Precision Science

Cutting-edge laboratory bioanalysis and pharmaceutical research training.

Collaborative Research
Global Synergy

A sustainable bridge of knowledge between Buffalo and Harare.

Strategic Mandates

Increase researchers with independent, funded programs focusing on HIV clinical pharmacology and therapeutics regional priorities.

Mentor scholars in team science including bioanalysis, informatics, data sciences, and traditional medicines.

Foster community engagement to study novel pharmacology strategies for long‑acting antiretrovirals and monoclonal antibodies.

Provide HIVRT that fosters smart academic‑public‑private partnerships for sustainable developmental goals.

Join the Research Pipeline